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Available online at www.sciencedirect.comDirect reprogramming of one cell type into another provides
unprecedented opportunities to study fundamental biology,
model disease, and develop regenerative medicine. Different
paradigms of reprogramming strategies with different sets of
factors have been developed to generate various cell types,
including induced pluripotent stem cells, neuronal or neural
precursor cells, cardiomyocyte-like cells, endothelial cells, and
hepatocyte-like cells. Various exogenous factors, especially
small molecules modulating signaling, cellular state, and
transcription, have been identified to enhance and enable
reprogramming. With an increased understanding of
reprogramming mechanisms and discovery of new molecules,
it is conceivable that reprogramming can be achieved in a more
directed and deterministic manner under entirely chemically
defined conditions.
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Introduction
Cell fate is controlled by both extrinsic factors (e.g.
signaling molecules) and intrinsic factors (e.g. endogen-
ous transcription factors). It has been shown that acti-
vation of the LIF-STAT3 and BMP-SMAD signaling
pathways are essential for the maintenance of murine
embryonic stem cells [1]. Transcription factors (TFs)
downstream of the signaling pathways orchestrate with
cell type-specific TFs, including Oct4, Sox2 and Nanog
that form an auto-regulatory loop, to govern cell fate [1].
Consistent with such mechanism, studies of TF-
mediated reprogramming demonstrated that cell fates
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example, fibroblasts can be induced into pluripotent stem
cells (iPSCs) by the Yamanaka factors (Oct4/Sox2/Klf4/c-
Myc), or converted to neuronal cells by Brn2/Ascl1/Myt1l
[2,3]. Mounting evidence demonstrates that extrinsic
factors can functionally mimic reprogramming TFs
and/or enhance reprogramming process to facilitate cell
fate switching. Here, we review these important extrinsic
drivers for somatic cell reprogramming.
Somatic cell reprogramming is regulated by
multiple signaling pathways
A successful iPSC reprogramming is to re-establish the
intrinsic pluripotency transcriptional network in somatic
cells. This network, in which Oct4 plays a pivotal role,
involves dozens of pluripotency-associated factors and
basal TFs [4].
Several signaling pathways have been reported to
regulate the pluripotency of ESCs, indicating that they
target certain components of the pluripotency transcrip-
tional network in ESCs. Changes in the chromatin state of
pluripotency genes, when driven by transduced factors or
other regulators during reprogramming, may allow these
signaling pathways to re-establish the pluripotency tran-
scriptional network (Figure 1). We begin this review with
a description of some of these key signaling molecules.
MEK-Erk
Inhibition of MEK and glycogen synthase kinase-3 (GSK-
3) by small molecule inhibitors PD0325901 and
CHIR99021 (2i) completely eliminated spontaneous
differentiation of ESCs in the absence of essential plur-
ipotency signaling pathway activation [5]. During repro-
gramming, PD0325901 was shown to stabilize and help to
select fully reprogrammed iPSCs [6]. Another study
suggested that at the late stage of reprogramming, the
2i/LIF condition promoted the transition from partially
reprogrammed cells to full iPSCs [7].
Wnt-GSK-3
Marson et al. showed that Wnt3a-conditioned medium
increased reprogramming efficiency in mouse embryonic
fibroblasts (MEFs) with ectopic expression of Oct4/Sox2/
Klf4 [8]. Similarly, it was demonstrated that CHIR99021
improved the reprogramming in the absence of c-Myc
and Sox2 [9]. A Wnt downstream regulator, Tcf3, was
reported to occupy the promoter regions of key pluripo-
tency genes, such as Oct4, Nanog and Sox2, to repress
their expression [10]. Thus, the positive effects of Wnt
pathway in reprogramming may be majorly mediated by
reduced Tcf3 activity.Current Opinion in Genetics & Development 2013, 23:519–525
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Important roles of signaling modulators and cellular state regulators in somatic cell reprogramming. Signaling modulators help to re-establish the
pluripotency transcriptional network during reprogramming triggered by exogenous key transcription factors, whereas cellular state regulators can
facilitate the shift from a somatic to a pluripotent cellular state.LIF-Stat3
Yang et al. demonstrated that LIF-Stat3 activation
increased somatic cell reprogramming efficiency using
a system that excluded the possibility of interference
by two other LIF-downstream pathways, PI3K-Akt and
MEK-Erk [11]. These findings suggest that the role of
LIF-Stat3 is to facilitate the transition from incompletely
reprogrammed cells (that are Oct4 negative and express
retroviral transgenes) into fully reprogrammed iPSCs.
PI3K-Akt
The role of the PI3K-Akt pathway in the reprogramming
process has not been fully elucidated. Nakamura et al.
showed that activation of Akt promoted reprogramming
after cell fusion of ESCs with thymocytes or MEFs [12].
In contrast, it also arrested transition from the two-cell to
eight-cell stage after nuclear transfer [12].
Other pathways
Regulation of other pathways, such as the cyclic AMP,
Hippo/Yap and Src family kinase pathways, was also
reported to increase reprogramming efficiency or func-
tionally replace certain Yamanaka factors [13–16].
Mechanisms that facilitate somatic
reprogramming by regulating cellular states
Several mechanisms have been reported to facilitate the
reprogramming process without direct activation of plur-
ipotency genes (Figure 1). However, it appears in many
cases that the more somatic cells are similar to pluripotent
cells, the easier it will be to convert them to pluripotent
cells. It is thus plausible that these additional mechanismsCurrent Opinion in Genetics & Development 2013, 23:519–525 facilitate the shift from a somatic to a pluripotent cellular
state.
Mesenchymal-to-epithelial transition and TGFb pathway
During the reprogramming process, fibroblasts lose
mesenchymal characteristics and obtain epithelial fea-
tures, suggesting that the MET process is critical during
reprogramming. This is consistent with findings showing
that when the TGFb pathway, which positively regulates
the epithelial-to-mesenchymal transition (EMT, a
reverse process of MET), was blocked by inhibitor of
TGFb receptor, there was a large increase in iPSC
generation [17]. Furthermore, the addition of a specific
TGFb receptor inhibitor could replace Sox2 in repro-
gramming [13]. Two follow-up studies provided molecu-
lar and functional evidence that the MET is necessary for
reprogramming [18,19].
Metabolic shift
It is evident that, compared with somatic cells, many
stem cells (including ESCs) rely more heavily on aerobic
glycolysis to support their proliferation [20]. Thus, the
transition from oxidative phosphorylation to glycolysis
was suggested to be a barrier of somatic reprogramming.
The findings showing that hypoxic conditions improved
reprogramming support this notion [21]. It was found
that PS48, an activator of 30-phosphoinositide-depend-
ent kinase 1, helped to generate human iPSC with
ectopic expression of a single TF (OCT4) by facilitating
the metabolic conversion to glycolysis [22]. On the other
hand, 2-deoxyglucose, a general inhibitor of glycolysis,
greatly impaired iPSC generation [23]. Moreover,
the glycolysis transition preceded pluripotency genewww.sciencedirect.com
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it acts at an early stage.
Anti-senescence pathways
Upregulation of senescence control genes, including p53,
p16INK4a, and p21, was observed as an early event in
reprogramming of fibroblasts by the Yamanaka factors
[24]. Considering that somatic cells have limited prolif-
erative potential while iPSCs have unlimited capacity for
self-renewal, it is likely that cellular senescence is a
barrier to reprogramming. This notion is consistent with
the observation that fibroblasts from older mice had lower
reprogramming efficiency [25]. Several groups pinpointed
the p53–p21 pathway as a critical barrier to reprogram-
ming [26]. They showed that knockdown of p53 in human
or mouse cells greatly increased iPSC generation.
Somatic cell reprogramming controlled by
gene expression regulators
As specific gene expression is central to cell identity,
there is no doubt that regulators of gene expression, such
as transcription factors, nuclear receptors, epigenetic
modifiers and microRNAs, have direct and strong effects
on cell fate determination.
Master transcription factors (TFs)
Reprogramming studies have demonstrated that combi-
nations of different cell type-specific TFs could be
applied to reprogram somatic cells directly into a variety
of cell types, including iPSCs, neuronal cells, cardiomyo-
cyte-like cells, hepatocyte-like cells, and endothelial
cells, that are similar to their naturally existing counter-
parts [2,3,27–31]. In addition, different reprogramming
paradigms have been developed. For example, applying
transient expression of iPSC factors can reset fibroblasts
toward plastic intermediates, which can be redirected by
lineage-specific signaling molecules to generate cardiac,
neural, or endothelial progenitor cells without passing
through the pluripotent state [29,32,33]. In contrast,
neural precursor cells could also be generated using
neural-specific TFs, such as Sox2 alone [34].
Nuclear receptors
Nuclear receptors are transcription factors that can
directly bind to DNA and regulate specific gene expres-
sion in a ligand-dependent or ligand-independent man-
ner. Like extensively studied master TFs for
pluripotency, some nuclear receptors were found to play
critical roles in iPSC reprogramming as well as the
maintenance of pluripotency. In addition to the well-
known core auto-regulatory loop of Oct4–Sox2–Nanog
[35], the nuclear receptor Esrrb could form another
regulatory circuit with Tbx3 and Tcl1 for the mainten-
ance of ESCs [36]. Furthermore, it was shown that Esrrb,
along with Oct4 and Sox2, could convert MEFs to iPSCs
[37]. In this process, Esrrb forms a complex with Oct4 and
Sox2, and synergistically upregulates the expression ofwww.sciencedirect.com pluripotency genes in MEFs. Remarkably, with the help
of other Yamanaka factors (Klf4/Sox2/c-Myc), another
orphan nuclear receptor, Nr5a2, was able to substitute for
Oct4 in iPSC generation [38]. In addition, Nr5a2 could
greatly enhance iPSC reprogramming in conjunction
with activation of another nuclear receptor, RARa/g
[39]. The finding that the RARa agonist (CD437) and
RARg agonist (AM580) dramatically increased repro-
gramming efficiency further supports the notion that
nuclear receptors play important roles in regulating
somatic cell reprogramming.
Epigenetic factors
Many studies demonstrated that small-molecule epige-
netic modifiers could significantly influence reprogram-
ming process and even substitute for certain
reprogramming transcription factors (Figure 2).
BIX01294, an inhibitor of G9a histone methyltransferase
(HMTase), was shown to enable reprogramming of neural
precursor cells or fibroblasts transduced with only two
TFs, Oct4 and Klf4 [6]. Besides well-known HDAC
inhibitors (e.g. VPA, NaB) that have been demonstrated
to facilitate reprogramming in various contexts [40,41],
Parnate, an inhibitor of histone demethylase LSD1, was
shown to enhance iPSC reprogramming as well [9]. Inter-
estingly, the well-known antioxidant compound vitamin
C was recently shown to enhance reprogramming by
modulating the activity of the histone demethylases
Jhdm1a/1b [42]. These findings highlight the dynamic
changes of histone modifications in reprogramming.
Recent mechanistic studies of iPSC reprogramming
further illustrated how epigenetic changes are orchestrated
in the early and late stages of reprogramming. Koche et al.
showed that activated chromatin marks (e.g. H3K4 meth-
ylation) were targeted to promoters of pluripotency and
developmentally regulated genes (e.g. Fgf4 and Lin28)
before transcriptional activation during the early phase of
iPSC reprogramming [43]. It was also reported that two
epigenetic factors, Parp1 and Tet2, were recruited to
pluripotency loci (e.g. Nanog and Esrrb) and established
early epigenetic marks by converting 5-methylcytosine
(5mC) into 5-hydroxymethylcytosine (5hmC) during repro-
gramming [44]. Interestingly, it was reported that along
with Klf4, Sox2, and c-Myc, another Tet family protein
Tet1 could enable somatic cell reprogramming in the
absence of the key transcription factor Oct4 or nuclear
receptors Esrrb and Nr5a2 [45], highlighting the important
role of DNA demethylation (through hydroxymethylation)
in reprogramming. Furthermore, other specific histone
modifications were identified to occur in reprogramming.
For example, inhibition of the H3K79 histone methyltrans-
ferase DOT1L (e.g. by a small molecule inhibitor) and the
H3K9 methyltransferase Setdb1 (e.g. by RNAi) was shown
to enhance iPSC generation [46,47]. These findings
indicate that histone methylations of both H3K79 and
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Master TFs
Target-cell genes activated by gene expression regulators and small molecules. (a) Showing transcriptional silence on target-cell gene loci (i.e.
pluripotency genes, neural genes, etc.) in fibroblasts. (b) These genes are activated by exogenous transcriptional regulators, including master
transcription factors (TFs), nuclear receptors (NRs), epigenetic co-activator, and related small molecules which can functionally mimic/substitute other
exogenous regulators. In addition, microRNAs for reprogramming usually form an inhibitory network to block the path toward other cell fates and
thereby facilitate a specific reprogramming process.
Current Opinion in Genetics & Development 2013, 23:519–525 www.sciencedirect.com
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certain epigenetic changes during reprogramming [48].
As Thy1 (a fibroblast marker) is linearly downregulated
and SSEA1 and Oct4 are linearly upregulated during
reprogramming, the reprogramming process in this study
was roughly divided into three stages: early (day 3,
Thy1), intermediate (days 6–9, SSEA1+), and late
(day 12, Oct4+). To determine certain epigenetic profiles
in the different stages of reprogramming, ChIP-seq
analyses were performed using antibodies against
H3K4me3 (an active histone mark) and H3K27me3 (a
repressive histone mark) in cells undergoing reprogram-
ming. It was found that the genes carrying H3K4me3
marks were activated early or gradually (e.g. Fbx15,
Cdc25c), whereas genes that were activated late (e.g.
Oct4, Nanog) were often either unmarked with
H3K4me3 or marked with both H3K4me3 and
K3K27me3 in fibroblasts. It was also found that the
demethylation of DNA did not happen until the late
stage of reprogramming.
MicroRNAs
It was demonstrated that some mouse ESC-specific, cell-
cycle-regulating (ESCC) microRNAs, including miR-
291-3p, miR-294, and miR-295, could substitute c-Myc
and enhance iPSC reprogramming with Oct4/Sox2/Klf4
[49]. Moreover, Subramanyam et al. showed that human
ESCC miRNA orthologs hsa-miR-302b and hsa-miR-372
promoted human somatic cell reprogramming through
multiple targets, including cell cycle regulators, epige-
netic modifiers, and MET regulators [50]. In addition to
iPSC generation, microRNAs were also shown as power-
ful regulator for lineage-specific reprogramming. It was
reported that miR-9* and miR-124 were found to directly
induce human fibroblasts into neurons with NeuroD2,
Ascl1, and Myt1l [51]. It was also demonstrated that miR-
124 in conjunction with Brn2 and Mytl1 could convert
human adult fibroblasts into mature neurons, suggesting
that miR-124 plays an important role in neuronal speci-
fication [52]. This finding also was supported by recent
studies in which knocking down a single RNA-binding,
polypyrimidine-tract-binding (PTB) protein could gen-
erate mature neurons from mouse fibroblasts via the
action of miR-124 [53].
Perspectives
Among these exogenously delivered factors, small mol-
ecules and microRNAs, which can be chemically syn-
thesized and do not modify target cell genome, have
emerged as powerful tools to manipulate cell fate. While
microRNAs offer the advantage of specifically targeting a
large number of genes, small molecules provide precise
temporal and tunable control over protein function, in-
cluding rapid and reversible activation and inhibition.
With an increased understanding of reprogramming
mechanisms and discovery of new molecules, it is con-
ceivable that reprogramming can be achieved in a morewww.sciencedirect.com efficient and deterministic manner under entirely chemi-
cally defined conditions.
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